A Drug-drug Interaction (DDI) Study of Morphothiadine Mesilate/Ritonavir in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Chronic Hepatitis B
Related studies linked through entity extraction aliases.
A Post-marketing Surveillance to Assess Safety and Efficacy of Besivo
- Status
- UNKNOWN
- Phase
- N/A
The Safety, Antiviral Activity, and Pharmacokinetics of Morphothiadine Mesilate Capsules
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Safety, Tolerability, and Antiviral Activity of Selgantolimod (Formerly GS-9688) in Viremic Adult Participants With Chronic Hepatitis B (CHB) Who Are Not Currently on Treatment
- Status
- COMPLETED
- Phase
- PHASE2
APG-1387 Study of Safety, Tolerability ,PK/PD in Patients With Chronic Hepatitis B
- Status
- COMPLETED
- Phase
- PHASE1
A Study Evaluating ABI-H0731+ Entecavir vs Entecavir Alone for the Treatment of Viremic HBeAg-positive Participants With Chronic Hepatitis B Virus Infection (cHBV)
- Status
- COMPLETED
- Phase
- PHASE2
A Study Evaluating ABI-H0731 as Adjunctive Therapy in Participants With Chronic Hepatitis B Infection
- Status
- COMPLETED
- Phase
- PHASE2
Hepatitis B Immune Globulin (HBIg) to Restore Immune Control in People With Chronic Hepatitis B
- Status
- WITHDRAWN
- Phase
- PHASE2
Treatment Efficacy and Safety of TDF-TAF Switch Study in South Korea
- Status
- UNKNOWN
- Phase
- N/A
Safety, Tolerability and Antiviral Activity of Selgantolimod in Virally-Suppressed Participants With Chronic Hepatitis B
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Combination Therapy of Thymalfasin and Entecavir in HBeAg-positive ETV-experienced Patients
- Status
- UNKNOWN
- Phase
- PHASE4
A Study of Orally Administered JNJ-440 to Evaluate the Safety, Tolerability, and Pharmacokinetics After Single Ascending Doses Including Food Effect Evaluation; After Multi-Day Dosing in Healthy Participants; and After Multiple (Ascending) Doses in Participants With Chronic Hepatitis B
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate the Safety and Antiviral Activity of Inarigivir Soproxil (Formerly: GS-9992) Plus Tenofovir Alafenamide (TAF) for 12 Weeks in Adults With Chronic Hepatitis B (CHB)
- Status
- TERMINATED
- Phase
- PHASE2
Study on Effect of Intestinal Microbiota Transplantation in Chronic Hepatitis B
- Status
- UNKNOWN
- Phase
- NA
Improvement of Hard Endpoint in Chronic Hepatitis B Patients Treated With Antiviral Therapy
- Status
- UNKNOWN
- Phase
- N/A
A Real-World Study of Pegylated Interferon In Nucleoside-treated Patients With Chronic Hepatitis B
- Status
- UNKNOWN
- Phase
- PHASE4
Change of Renal Function and Bone Mineral Density in CHB Patients Switch From TDF to TAF vs. Maintaining TDF
- Status
- COMPLETED
- Phase
- PHASE4
Magnesium Isoglycyrrhizinate Followed by Diammonium Glycyrrhizinate and Combined With Entecavir in Chronic Hepatitis B
- Status
- UNKNOWN
- Phase
- PHASE4
Sequential/Combination Therapy in Nucleoside or Nucleotide Analogue (NA)-Suppressed Chronic Hepatitis B Patients
- Status
- UNKNOWN
- Phase
- PHASE4
The Effect of Entecavir Consolidation on Post-TDF Treatment Durability
- Status
- UNKNOWN
- Phase
- PHASE4